Redeye comments on Physitrack ahead of its Q2 results, due on 18 July (rescheduled from 31 July).
Two different pictures in the company While both Nordics & Baltics and the UK progressed well with p...
Q2 details Sales SEK 1,172m (0% vs ABG 1,170m, no cons).
Redeye sees a stable Q2 report from Addnode, with the relatively solid performance in PLM being the ...
Redeye provides its initial take on OEM’s Q2 2025 report, which came in below our estimates.
Earnings growth may not resume before Q4’25 DT cut Q2 guidance as security CT installations remaine...
Redeye updates its estimates following Waystream’s Q2 report last week.
Q2 EBITDA of NOK 7m StrongPoint showed a positive development with sales +18% y-o-y, mostly driven b...
We lower adjusted EBITA by a mere 1% following the Q2 report, which saw adjusted EBITA drop by 22% y...
Q2 results Coor continued the positive trend and delivered better earnings than expected in Q2 while...
Scanfil buys MB Elettronica which has 4 factories in Italy.
Redeye comments on Hexatronic’s Q2 report, showing numbers aligning with the preliminary figures.
- Q2 sales SEK 30m, EBIT -4.7m (vs. ABGSCe 37m and -0.
Redeye comments on Alligator Bioscience's second quarter report 2025.
We estimate Q2 2025 pre-tax profit of DKK 69m, down DKK 36m (34%) y/y.
